News

Researchers identify new genes linked to longer reproductive lifespan in women

Aug 9, 2021

On the 4th of August Nature published the findings from a global collaboration of scientists, who have identified nearly 300 gene variations that influence reproductive lifespan in women. This can lead to potential new targets for fertility treatments as well as ways to improve the prediction of early menopause.

“The average age of Danish women having their first child has risen from 23 to 29 over the past 60 years. This means that more people need fertility treatments such as IVF, which are expensive and stressful. Many women need to go through multiple cycles of treatment because the hormonal treatment does not always work. Our research has identified exciting new targets that could lead to improved fertility treatment,” says one of four co-leaders of the study, Professor Eva Hoffmann in a news release from the Faculty of Health and Medical Sciences, University of Copenhagen.

The researchers studied genetic data from 200,000 women of European ancestry and found 290 genetic variations linked to reproductive lifespan. “We found five times as many genetic factors than were known previously,” said study author Dr John Perry from the University of Cambridge to the Guardian. “In terms of what we know about the genetics of menopause, it’s a huge leap forward.”

One of the key aims of the study was to help predict a woman’s natural fertility window. “There are some tests that can measure hormones that indicate if a woman has a low ovarian reserve but by the time it is detected the decline has already begun – there’s no long-term predictor of when the decline will begin,” said John Perry. Further research could help identify some women who are at relatively high risk compared with others, he added. “Ultimately, what we’re working towards is this sort of predictive test where you could analyse someone’s DNA, and then try to infer what their natural fertility window would be … then women can make more informed reproductive choices,” concluded Dr Perry in the Guardian article.

The news was also featured by NewScientist and BioNews where you can find a list of further sources and references.

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more